Karyomapping: Advancing PGD for Single Gene Disorders| Illumina Video

November 19, 2014

In preimplantation genetic diagnosis (PGD), karyomapping is a highly accurate, DNA-based method that detects single-gene variations implicated in inherited diseases in embryos following IVF. For the first time, one test can deliver timely information about many variants implicated in inherited conditions,. Learn more about the latest advances in reproductive and genetic health solutions from Illumina. [link to RGH page http://www.illumina.com/clinical/reproductive-genetic-health.ilmn] Excerpt from an interview with Professor Alan Handyside, MA, PhD Principal Scientist, Reproductive and Genetic Health, Illumina.

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.